Skip to main content
logo
Agios Pharmaceuticals, Inc. (AGIO)
NASDAQ: AGIO · Real-Time Price · USD
29.46
+0.74 (2.58%)
At close: Jun 12, 2026, 4:00 PM EDT
29.94
+0.48 (1.63%)
Pre-market: Jun 15, 2026, 7:39 AM EDT

Agios Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-422.6-412.78673.73-352.09-231.81,605
Depreciation & Amortization
5.265.185.656.628.569.24
Stock-Based Compensation
56.7352.5542.8544.7749.353.51
Other Adjustments
10.5315.12-1,09223.69-119.116.5
Change in Receivables
-12.79-6.47-1.3-0.6-1.76-4.38
Changes in Inventories
-5.48-5.3-8.54-10.58-8.49-
Changes in Accounts Payable
-0.431.756.6-8.733.441.86
Changes in Accrued Expenses
-2.71-1.43.6912.82-1.620.07
Changes in Income Taxes Payable
-0.68-0.870.87---
Changes in Other Operating Activities
-21.1-20.74-21.1-11.95-8-34.37
Operating Cash Flow
-380.41-372.98-389.84-296.06-309.48-407.32
Capital Expenditures
-4.32-4.32-1.69-1-4.88-
Sale of Property, Plant & Equipment
--0.041.330.96-
Purchases of Investments
-615.04-641.76-1,542-417.93-1,031-1,378
Proceeds from Sale of Investments
1,0351,033818.38674.681,146829.8
Other Investing Activities
-5-101,089-17.5131.78-5.74
Investing Cash Flow
405.91377.18363.44239.58243.261,249
Issuance of Common Stock
9.148.6814.445.432.6837.3
Repurchase of Common Stock
------802.49
Net Common Stock Issued (Repurchased)
9.148.6814.445.432.68-765.19
Other Financing Activities
-----0.33-0.58
Financing Cash Flow
6.588.6814.445.432.35-765.77
Net Cash Flow
34.6412.88-11.96-51.05-63.8775.69
Free Cash Flow
-384.73-377.29-391.53-297.06-314.36-407.32
FCF Margin
-582.50%-698.33%-1072.73%-1107.49%-2207.58%-
Free Cash Flow Per Share
-6.60-6.51-6.76-5.34-5.74-6.74
Levered Free Cash Flow
-452.06-438.49659.22-364.92-242.791,582
Unlevered Free Cash Flow
-502.71-496.69-414-404.32-400.04-401.62
SEC Filings: 10-K · 10-Q